Type II Polycystic Ovary Syndrome
Conditions
Interventions
super-long GnRHa protocol group and long GnRHa protocol group with daily GnRHa:women in type II Polycystic Ovary Syndrome (PCOS) undergo different down-regulation protocols , super-long GnRHa protocol
Sponsors
He'nan Provincial People's Hospital
Eligibility
Sex/Gender
Female
Age
24 Years to 37 Years
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria will be enrolled: (1) Aged 24-37 years; (2) diagnosed with type II PCOS according to the Rotterdam criteria; (3) plan to undergo IVF-ET at our hospital; (4) have not undergone any previous IVF-ET; (5) patients sign the informed consent.;Inclusion criteria: Patients who meet all of the following criteria will be enrolled: (1) Aged 24-37 years; (2) diagnosed with type II PCOS according to the Rotterdam criteria; (3) plan to undergo IVF-ET at our hospital; (4) have not undergone any previous IVF-ET; (5) patients sign the informed consent.;Inclusion criteria: Patients who meet all of the following criteria will be enrolled: (1) Aged 24-37 years; (2) diagnosed with type II PCOS according to the Rotterdam criteria; (3) plan to undergo IVF-ET at our hospital; (4) have not undergone any previous IVF-ET; (5) patients sign the informed consent.;Inclusion criteria: Patients who meet all of the following criteria will be enrolled: (1) Aged 24-37 years; (2) diagnosed with type II PCOS according to the Rotterdam criteria; (3) plan to undergo IVF-ET at our hospital; (4) have not undergone any previous IVF-ET; (5) patients sign the informed consent.;Inclusion criteria: Patients who meet all of the following criteria will be enrolled: (1) Aged 24-37 years; (2) diagnosed with type II PCOS according to the Rotterdam criteria; (3) plan to undergo IVF-ET at our hospital; (4) have not undergone any previous IVF-ET; (5) patients sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) presence of hydrosalpinx complicated by reflux of hydrosalpinx fluid into the uterine cavity; (2) a history of organic lesions of the uterus (e.g., intrauterine tuberculosis, intrauterine adhesion) and uterine malformation.;Exclusion criteria: (1) presence of hydrosalpinx complicated by reflux of hydrosalpinx fluid into the uterine cavity; (2) a history of organic lesions of the uterus (e.g., intrauterine tuberculosis, intrauterine adhesion) and uterine malformation.;Exclusion criteria: (1) presence of hydrosalpinx complicated by reflux of hydrosalpinx fluid into the uterine cavity; (2) a history of organic lesions of the uterus (e.g., intrauterine tuberculosis, intrauterine adhesion) and uterine malformation.;Exclusion criteria: (1) presence of hydrosalpinx complicated by reflux of hydrosalpinx fluid into the uterine cavity; (2) a history of organic lesions of the uterus (e.g., intrauterine tuberculosis, intrauterine adhesion) and uterine malformation.;Exclusion criteria: (1) presence of hydrosalpinx complicated by reflux of hydrosalpinx fluid into the uterine cavity; (2) a history of organic lesions of the uterus (e.g., intrauterine tuberculosis, intrauterine adhesion) and uterine malformation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate; | — |
Countries
China
Contacts
Public ContactShaodi Zhang;Shaodi Zhang;Shaodi Zhang;Shaodi Zhang;Shaodi Zhang ;;;;
He'nan Provincial People's Hospital;He'nan Provincial People's Hospital;He'nan Provincial People's Hospital;He'nan Provincial People's Hospital;He'nan Provincial People's Hospital
Outcome results
None listed